Carnegie Investment Counsel’s Eastman Chemical EMN Stock Holding History

Carnegie Investment Counsel’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,300	Closed	-$257K	–	420
2019 Q2	$257K	Hold	3,300	–	–	0.02%	378
2019 Q1	$250K	Hold	3,300	–	–	0.02%	368
2018 Q4	$241K	Buy	+3,300	New	+$263K	0.02%	329
2018 Q3	–	Sell	-3,300	Closed	-$327K	–	355
2018 Q2	$327K	Hold	3,300	–	–	0.02%	311
2018 Q1	$352K	Hold	3,300	–	–	0.03%	286
2017 Q4	$327K	Hold	3,300	–	–	0.03%	314
2017 Q3	$293K	Hold	3,300	–	–	0.03%	293
2017 Q2	$277K	Buy	+3,300	New	+$266K	0.03%	299

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carnegie Investment Counsel's EMN Position: Q3 2019 in Review

Carnegie Investment Counsel sold out of Eastman Chemical (EMN) in Q3 2019, closing a stake of 3,300 shares — an estimated $257K sold.

Carnegie Investment Counsel first reported a position in EMN in Q2 2017 and held it in 8 quarters. The position peaked at $352K in Q1 2018. 623 funds tracked by Wall St. Rank hold EMN as of Q3 2019.

Carnegie Investment Counsel reported no remaining Eastman Chemical position as of Q3 2019 after selling out during the quarter.
Carnegie Investment Counsel sold 3,300 Eastman Chemical shares in Q3 2019, an estimated $257K.
Carnegie Investment Counsel first reported a position in Eastman Chemical in Q2 2017 and held it in 8 quarters.
Carnegie Investment Counsel's Eastman Chemical position peaked at $352K in Q1 2018.
623 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2019.

Based on Carnegie Investment Counsel's 13F filing for Q3 2019, filed 20 Nov 2019.